X-135901610-A-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001381902.1(SAGE1):​c.139A>C​(p.Lys47Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,208,059 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000011 ( 0 hom. 8 hem. )

Consequence

SAGE1
NM_001381902.1 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.40
Variant links:
Genes affected
SAGE1 (HGNC:30369): (sarcoma antigen 1) This gene belongs to a class of genes that are activated in tumors. These genes are expressed in tumors of different histologic types but not in normal tissues, except for spermatogenic cells and, for some, placenta. The proteins encoded by these genes appear to be strictly tumor specific, and hence may be excellent sources of antigens for cancer immunotherapy. This gene is expressed in sarcomas. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03454417).
BS2
High Hemizygotes in GnomAdExome4 at 8 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SAGE1NM_001381902.1 linkc.139A>C p.Lys47Gln missense_variant Exon 3 of 20 ENST00000370709.4 NP_001368831.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SAGE1ENST00000370709.4 linkc.139A>C p.Lys47Gln missense_variant Exon 3 of 20 5 NM_001381902.1 ENSP00000359743.3 Q9NXZ1
SAGE1ENST00000324447.8 linkc.139A>C p.Lys47Gln missense_variant Exon 3 of 20 5 ENSP00000323191.3 Q9NXZ1

Frequencies

GnomAD3 genomes
AF:
0.0000267
AC:
3
AN:
112165
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
34309
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000948
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.000663
GnomAD3 exomes
AF:
0.0000164
AC:
3
AN:
182401
Hom.:
0
AF XY:
0.0000149
AC XY:
1
AN XY:
67007
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000530
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000246
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000110
AC:
12
AN:
1095894
Hom.:
0
Cov.:
27
AF XY:
0.0000221
AC XY:
8
AN XY:
361330
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000130
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000595
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000267
AC:
3
AN:
112165
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
34309
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000948
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.000663
Bravo
AF:
0.00000378
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 01, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.139A>C (p.K47Q) alteration is located in exon 3 (coding exon 2) of the SAGE1 gene. This alteration results from a A to C substitution at nucleotide position 139, causing the lysine (K) at amino acid position 47 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.22
DANN
Benign
0.32
DEOGEN2
Benign
0.0018
T;T;T
FATHMM_MKL
Benign
0.0063
N
LIST_S2
Benign
0.40
T;T;.
M_CAP
Benign
0.0022
T
MetaRNN
Benign
0.035
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;.;N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.12
N;N;N
REVEL
Benign
0.0080
Sift
Benign
0.40
T;T;T
Sift4G
Benign
0.42
T;T;T
Polyphen
0.015
B;B;B
Vest4
0.031
MutPred
0.30
Loss of methylation at K47 (P = 0.0127);Loss of methylation at K47 (P = 0.0127);Loss of methylation at K47 (P = 0.0127);
MVP
0.014
ClinPred
0.039
T
GERP RS
-3.1
Varity_R
0.054
gMVP
0.012

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs781996594; hg19: chrX-134983769; API